Evidence map›Paper›PMID 32566859›Full record

ArticleACS omega2020

Levoglucosenone and Its Pseudoenantiomer

Xin Liu, Paul Carr, Michael G Gardiner, Martin G Banwell, Ahmed H Elbanna, Zeinab G Khalil, Robert J Capon

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Oxa-Michael-initiated cascade reactions of levoglucosenone.Beilstein journal of organic chemistry · 2022
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xin LiuResearch School of Chemistry, Institute of Advanced Studies, The Australian National University, Canberra, ACT 2601, Australia.
Paul CarrResearch School of Chemistry, Institute of Advanced Studies, The Australian National University, Canberra, ACT 2601, Australia.
Michael G GardinerResearch School of Chemistry, Institute of Advanced Studies, The Australian National University, Canberra, ACT 2601, Australia.
Martin G BanwellResearch School of Chemistry, Institute of Advanced Studies, The Australian National University, Canberra, ACT 2601, Australia.
Ahmed H ElbannaInstitute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia.
Zeinab G KhalilInstitute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia.
Robert J CaponInstitute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The bioderived platform molecule levoglucosenone (LGO,

Identifiers

PMID32566859
PMCPMC7301580

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.